fda warning letters compounded semaglutide tirzepatide september 2025 Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP-1 compounding while @martymakary is photographed holding bootleg # Compound versions of GLP-1 drugs
Description
Inoue K., Maeda N., Kashine S., Fujishima Y., Kozawa J., Hiuge-Shimizu A., et al

Aim for 1.2 to 2 grams of protein per kilogram of body weight

Tirzepatide has garnered attention for its promising outcomes, especially concerning weight management

[DOI] [PubMed] [Google Scholar] 509.Refardt J, et al

Explore, learn, and connect with a trusted supplier dedicated to advancing your research outcomes

Oral semaglutide increases levothyroxine exposure, so thyroid function should be monitored in patients taking both medications
